Skip to main content

Packaging, labelling and marketing of pharmaceuticals has evolved rapidly in India, with concerns about ‘deceptive similarity’ at the helm. Our Pharma Dossier (Vol. 1) discusses trade mark jurisprudence in light of the primary factor – the consumer.

Whereas differentiation on the basis of a name may have become more constrictive, creative use of unconventional marks and branding exercises by pharmaceutical companies has aided the creation of unique identities. Useful, with the rate e-pharmacies are disrupting traditional distribution models.

 

To read more, contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Oct 02, 2025

‘First published on India Business Law Journal’ By: Pravin Anand and Dr. Ajai Garg The fourth industrial revolution, driven by artificial intelligence

Independent AI key to India’s global power
News & Updates
Sep 15, 2025

Aishwarya Rai Bachchan & Abhishek Bachchan personality rights case Dhruv Anand talks to PTI TV about the significance of the order passed by the Delhi

Aishwarya Rai & Abhishesk Bachchan personality rights: Dhruv Anand’s exclusive with PTI TV
News & Updates
Sep 12, 2025

Aishwarya Rai Bachchan personality rights case: As Delhi HC grants interim protection to the Actor, Mr Pravin Anand spoke exclusively to ANI (Asian News

Aishwarya Rai personality case: Pravin Anand’s exclusive with ANI
News & Updates
Sep 12, 2025

Team Anand and Naik recently represented Mr. Abhishek Bachchan before the Delhi High Court, helping him secure his personality and publicity rights. Hon’ble

Team Anand and Naik Secures Personality Rights Protection for Mr. Abhishek Bachchan